Avidity Partners Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-172,000
| Closed | -$49.7M | – | 94 |
|
|
2022
Q4 | $49.7M | Sell |
172,000
-340,800
| -66% | -$98.4M | 1.08% | 30 |
|
|
2022
Q3 | $148M | Sell |
512,800
-280,200
| -35% | -$81.1M | 3.02% | 7 |
|
|
2022
Q2 | $223M | Buy |
793,000
+247,400
| +45% | +$69.7M | 5.13% | 2 |
|
|
2022
Q1 | $142M | Buy |
545,600
+265,600
| +95% | +$69.3M | 2.96% | 10 |
|
|
2021
Q4 | $61.5M | Sell |
280,000
-646,400
| -70% | -$142M | 1.3% | 28 |
|
|
2021
Q3 | $168M | Sell |
926,400
-23,600
| -2% | -$4.28M | 3.72% | 4 |
|
|
2021
Q2 | $192M | Buy |
950,000
+639,100
| +206% | +$129M | 5.18% | 1 |
|
|
2021
Q1 | $66.8M | Buy |
310,900
+163,600
| +111% | +$35.2M | 1.85% | 16 |
|
|
2020
Q4 | $34.8M | Buy |
+147,300
| New | +$34.8M | 1.13% | 31 |
|
|
2020
Q2 | – | Sell |
-34,000
| Closed | -$8.09M | – | 76 |
|
|
2020
Q1 | $8.09M | Sell |
34,000
-6,000
| -15% | -$1.43M | 1.12% | 31 |
|
|
2019
Q4 | $8.76M | Buy |
+40,000
| New | +$8.76M | 5.52% | 3 |
|